Garcia-Perez Juan Carlos, Rodríguez-Perez Rosa, Ballestero Araceli, Zuloaga Jaime, Fernandez-Puntero Belen, Arias-Díaz Javier, Caballero María Luisa
From the Department of Surgery, Hospital Ramón y Cajal (JCG-P, AB), La Paz University Hospital Institute for Health Research (IdiPAZ) (RR-P), Department of Surgery, Complutense University, Hospital Clínico San Carlos (JZ, JA-D), Department of Clinical Laboratory, La Paz University Hospital (BF-P); and Department of Allergy, La Paz University Hospital, Institute for Health Research (IdiPAZ), Madrid, Spain (MLC).
Medicine (Baltimore). 2015 Oct;94(40):e1699. doi: 10.1097/MD.0000000000001699.
Anisakiasis is a global disease caused by consumption of raw or lightly cooked fish contaminated with L3 Anisakis spp. larvae. High rates of parasitization of fish worldwide make Anisakis a serious health hazard. In fact, anisakiasis is a growing disease in countries such as Spain, Italy, and Japan, where consumption of raw/marinated fish is high. Some parasitic infections have been recognized as a causative factor for human cancer. Suggested mechanisms include chronic inflammation elicited by the parasite, and a possible tumorigenic effect from certain parasitic secretions. Anisakis can produce persistent local inflammation and granuloma, and larvae have been incidentally found in gastrointestinal (GI) tumors. Our aim was to discover possible differences in the prevalence of unnoticed or asymptomatic previous Anisakis infection in GI cancer patients compared with healthy individuals. Serum levels of specific antibodies against Anisakis antigens were used as a reliable marker of previous contact with their larvae. Ninety-four participants without a previous history of Anisakis infection were prospectively allocated into 1 of 2 groups: 47 patients with GI cancer and 47 controls. Specific IgE, IgA1, and IgG1 against the Anisakis recombinant antigens Ani s 1, Ani s 5, Ani s 9, and Ani s 10 were determined by an ELISA assay. The ratio of positivity to sIgA1, rAni s 1, or rAni s 5 was significantly higher in the cancer patients than in the controls (38.30% vs 6.38%, P < 0.001) and (42.55% vs 10.64%, P < 0.001, respectively). When disaggregated by type of tumor, the patients with gastric cancer showed a higher proportion of positive results for sIgA1 to rAni s 1 (P < 0.001), whereas a higher proportion of colon cancer patients were shown to be positive for sIgA1 to both rAni s 1 (P < 0.05) and rAni s 5 (P < 0.01). Earlier Anisakis infection might be a risk factor for the development of stomach or colon cancer.
异尖线虫病是一种全球性疾病,由食用受L3期异尖线虫属幼虫污染的生鱼或轻度烹饪的鱼引起。全球鱼类的高寄生率使异尖线虫成为严重的健康危害。事实上,在西班牙、意大利和日本等生鱼/腌制鱼消费量高的国家,异尖线虫病的发病率正在上升。一些寄生虫感染已被确认为人类癌症的致病因素。推测的机制包括寄生虫引发的慢性炎症,以及某些寄生虫分泌物可能产生的致瘤作用。异尖线虫可引起持续性局部炎症和肉芽肿,并且在胃肠道(GI)肿瘤中偶然发现幼虫。我们的目的是发现与健康个体相比,胃肠道癌症患者中未被注意到或无症状的既往异尖线虫感染患病率可能存在的差异。血清中抗异尖线虫抗原的特异性抗体水平被用作既往接触其幼虫的可靠标志物。94名无既往异尖线虫感染史的参与者被前瞻性地分为2组中的1组:47例胃肠道癌症患者和47名对照。通过酶联免疫吸附测定(ELISA)检测针对异尖线虫重组抗原Ani s 1、Ani s 5、Ani s 9和Ani s 10的特异性IgE、IgA1和IgG1。癌症患者中sIgA1、rAni s 1或rAni s 5的阳性率显著高于对照组(分别为38.30%对6.38%,P<0.001)和(42.55%对10.64%,P<0.001)。按肿瘤类型分类时,胃癌患者中sIgA1对rAni s 1的阳性结果比例更高(P<0.001),而结肠癌患者中sIgA1对rAni s 1(P<0.05)和rAni s 5(P<0.01)两者的阳性比例更高。既往异尖线虫感染可能是胃癌或结肠癌发生的一个危险因素。